Dino Mehic/LinkedIn
Dec 14, 2025, 13:14
Dino Mehic with Colleagues: BDUC – What is It and What Do We Know?
Dino Mehic, Physician Scientist at the Medical University of Vienna, shared on LinkedIn:
“Bleeding Disorder of Unknown Cause (BDUC): What Do We Know?
- We are excited to share that we recently summarized nearly two decades of clinical and research experience in the management of patients with bleeding disorders of unknown cause (BDUC).
- This review represents a long-standing, collaborative effort to better understand the natural history of BDUC led by Ingrid Pabinger, Johanna Gebhart, and Cihan Ay at our institution (Medical University of Vienna).
- At the American Society of Hematology 2025 Annual Meeting in Orlando, Prof. Pabinger presented our current understanding of how to predict and treat BDUC-an important step toward improving care for this under-recognized patient population.
Title: Predictors for future bleeding in bleeding disorder of unknown cause
Authors: Tim Dreier, Dino Mehic, Cihan Ay, Johanna Gebhart, Ingrid Pabinger
Link to the publication in ASH Hematology”
Stay informed with ASH2025 updates on Hemostasis Today.
-
Jan 30, 2026, 11:38Aaron Rodriguez Calienes on Intracranial Stenting: Rescue vs First-Line Outcomes
-
Jan 30, 2026, 11:25Ahmed Nasreldein on Sex Disparities in Thrombolysis Delay Among Egyptian Stroke Patients
-
Jan 30, 2026, 11:17Yanki Yarman: My PhD Project Has Been Published in Blood!
-
Jan 30, 2026, 11:08Alexandros Apostolou on Complications Associated with IDU and Thrombophilia
-
Jan 30, 2026, 10:57Peisong Ma on GRK5 Polymorphism Affecting Platelets
-
Jan 30, 2026, 10:47Ashok Yadav Explains Fetal Thrombotic Vasculopathy: FTV
-
Jan 30, 2026, 10:34Saif ur Rahman Compares K2 and K3 EDTA: Key Differences Explained
-
Jan 30, 2026, 10:22Manpreet Gill on Heparin Resistance: When 14 Years of Experience Finally Gets a Plot Twist
-
Jan 30, 2026, 10:14Mohamed Elsaid on The Role of Hyperlipidemia in Thrombogenesis